Cargando…

The Development Pathway for Biosimilar Biotherapeutics

Detalles Bibliográficos
Autor principal: Zarbin, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PUBLISHED BY KNOWLEDGE E 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431720/
https://www.ncbi.nlm.nih.gov/pubmed/32864056
http://dx.doi.org/10.18502/jovr.v15i3.7444
_version_ 1783571642353451008
author Zarbin, Marco
author_facet Zarbin, Marco
author_sort Zarbin, Marco
collection PubMed
description
format Online
Article
Text
id pubmed-7431720
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher PUBLISHED BY KNOWLEDGE E
record_format MEDLINE/PubMed
spelling pubmed-74317202020-08-28 The Development Pathway for Biosimilar Biotherapeutics Zarbin, Marco J Ophthalmic Vis Res Editorial PUBLISHED BY KNOWLEDGE E 2020-07-29 /pmc/articles/PMC7431720/ /pubmed/32864056 http://dx.doi.org/10.18502/jovr.v15i3.7444 Text en Copyright © 2020 Zarbin. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Editorial
Zarbin, Marco
The Development Pathway for Biosimilar Biotherapeutics
title The Development Pathway for Biosimilar Biotherapeutics
title_full The Development Pathway for Biosimilar Biotherapeutics
title_fullStr The Development Pathway for Biosimilar Biotherapeutics
title_full_unstemmed The Development Pathway for Biosimilar Biotherapeutics
title_short The Development Pathway for Biosimilar Biotherapeutics
title_sort development pathway for biosimilar biotherapeutics
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431720/
https://www.ncbi.nlm.nih.gov/pubmed/32864056
http://dx.doi.org/10.18502/jovr.v15i3.7444
work_keys_str_mv AT zarbinmarco thedevelopmentpathwayforbiosimilarbiotherapeutics
AT zarbinmarco developmentpathwayforbiosimilarbiotherapeutics